DMD Systems Recovery, LLC (DMD) proudly announces its recognition on the 2025 MO 100 Top Impact CEO Ranking for the third consecutive year, reinforcing its commitment to sustainable and responsible ...

The trial was able to elicit more than double the microdystrophin gene in patients after 90 days of treatment.

Less than half of patients had undergone bone monitoring, suggesting a need for better clinical guidance and management of ...

Solid Biosciences’ gene therapy uses a shortened version of the dystrophin protein, which is engineered to mimic the key ...

Medically reviewed by Smita Patel, DO Duchenne muscular dystrophy (DMD) is a rare neurological condition that causes severe muscle weakness and intellectual disability. DMD is an inherited (passed ...

Solid Biosciences has surged back into the Duchenne muscular dystrophy (DMD) gene therapy race. | Solid Biosciences has ...

Md Mostafizur Rahman has recently been appointed as a deputy managing director (DMD) of Citizens Bank PLC. Prior to joining ...

DMD Advocates advised Innov8 Workspaces India Limited on a secondary sale and primary investment by InCred Wealth and ...

Md Mostafizur Rahman has been appointed as deputy managing director of Citizens Bank PLC, said a press release. Prior to ...

Muscular dystrophy is a disease caused by a genetic mutation. The muscles of muscular dystrophy patients weaken.. | Genetics ...

The Duchenne muscular dystrophy (DMD) market is projected to grow from $2.3 billion in 2023 to $5.2 billion in 2033 across seven major markets, driven by recent approvals of novel therapies, says ...